| Net loss | -5.8M |
| Impairment loss and inventory valuation allowance | |
| Shares issued for services rendered | |
| Depreciation | 297.82K |
| Amortization of deferred financing costs | 35.81K |
| Stock compensation expense | 130.71K |
| Amortization of patents | |
| Amortization of long term contracts | |
| Amortization of purchased technology | |
| Accounts receivable | 465.01K |
| Inventory | 11.38K |
| Costs in excess of billings | |
| Prepaid and other current assets | -48.04K |
| Other assets | -32.92K |
| Accounts payable | -594.4K |
| Billings in excess of costs | |
| Accrued expenses | 828.02K |
| Net cash used in operating activities | -2.58M |
| Purchase of property and equipment | |
| Maturity of certificates of deposit | |
| Proceeds from marketable investments | |
| Net cash provided by investing activities | -280.98K |
| Proceeds from notes payable | 0 |
| Proceeds from convertible notes payable | |
| Proceeds from notes payable, related party | 1.14M |
| Repayment of notes payable | -519.6K |
| Repayment of notes payable, related party | -56.94K |
| Proceeds from the exercise of stock options | |
| Net cash provided by financing activities | 2.91M |
| Net increase (decrease) in cash and cash equivalents | 57.61K |
| Cash and cash equivalents at beginning of year | 67.16K |
| Cash and cash equivalents at end of period | 124.77K |
| Unrealized loss on marketable investments | |
| Shares issued as additional collateral | |
| Shares issued with debt | |
| Beneficial conversion feature | |
| Warrants issued | |
| Interest paid | 468.48K |
| Taxes paid | |